Interestingly, the change in IRE-IRP binding after treatment with FAC was more pronounced in HF fibroblasts than in control fibroblasts (non-HF: 60 ± 7%; HF: 24 ± 9%) (Figure 5b). The gene discussed is WNT2; the disease is hydrops fetalis.